DoseOptics has developed BeamSite, the first Cherenkov imaging system that provides real-time visualization of radiation therapy delivery, allowing clinicians to monitor treatment accuracy. This technology addresses the risk of suboptimal radiation treatment by enabling immediate detection of errors during the therapy process, enhancing patient safety and treatment effectiveness.
Funding
Funding not disclosed
Founders
Product
Problem
Radiation therapy, while effective, carries the risk of errors in delivery, potentially leading to suboptimal treatment and harm to patients. Current practices rely on careful alignment and calibration, but undetected inaccuracies can still occur, especially with increasingly complex treatment plans.
Solution
DoseOptics' BeamSite is a Cherenkov imaging system that provides real-time visualization of radiation therapy delivery, enabling clinicians to monitor treatment accuracy. The system captures the entire radiation therapy process, allowing for immediate detection and correction of errors during treatment. By providing visual verification of radiation delivery, BeamSite supports clinical teams in reducing errors, improving treatment quality, and enhancing patient safety. The technology empowers clinicians to identify inaccuracies that might otherwise go unnoticed, ensuring more precise and effective cancer treatment.
Target Audience
The primary audience includes radiation oncologists, medical physicists, radiation therapists, and hospital administrators seeking to improve the safety and effectiveness of cancer care.
Features
- Real-time video rate imaging of radiation delivery using Cherenkov imaging technology
- FDA-cleared for clinical use
- Easy-to-use, passive system that records all patient treatments
- BeamSite Research version available for research applications with tripod mountable, movable design, and customizable acquisition settings